Low-Dose Aspirin for Primary Prevention of Cardiovascular Events in Patients with Type 2 Diabetes: 10-year Follow-up of a Randomized Controlled Trial
Yoshihiko Saito, Sadanori Okada, Hisao Ogawa, Hirofumi Soejima, Mio Sakuma, Masafumi Nakayama, et al. and the JPAD Trial Investigators
Circulation. 2016; előzetes elektronikus közlés; Originally published November 15, 2016. http://dx.doi.org/10.1161/CIRCULATIONAHA.116.025760